(Q40084945)

English

Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome

scientific article published on September 1, 1981

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome (English)

1 reference

Europe PubMed Central

17 September 2017

Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome (English)

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

1 reference

based on heuristic

inferred from title

author name string

M. C. Houston

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115570

8 August 2023

language of work or name

0 references

publication date

1 September 1981

1 reference

Europe PubMed Central

17 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0002870381903173?httpAccept=text/xml

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

https://api.elsevier.com/content/article/PII:0002870381903173?httpAccept=text/plain

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

American Heart Journal

1 reference

Europe PubMed Central

17 September 2017

102

1 reference

Europe PubMed Central

17 September 2017

415-430

1 reference

Europe PubMed Central

17 September 2017

3 Pt 1

1 reference

Europe PubMed Central

17 September 2017

Arterial pressure responses to discontinuing antihypertensive drugs

1

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Studies on the control of hypertension. 8. Mortality, morbidity, and remissions during twelve years of intensive therapy

3

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Return of elevated blood pressure after withdrawal of antihypertensive drugs

5

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

6

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Central nervous system actions of clonidine in hypertension

7

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline

8

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients

9

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Blood pressure and heart rate and withdrawal of antihypertensive drugs

11

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal Syndrome Following Cessation of Guanabenz Therapy

12

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effects of methyldopa in fifty hypertensive patients

13

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Rebound hypertension after acute methyldopa withdrawal

14

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Acute clonidine withdrawal syndrome following open-heart operation.

15

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Propranolol and polythiazide in treatment of hypertension

16

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine hydrochloride withdrawal complicating bilateral nephrectomy

17

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents

18

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

19

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Letter: Clonidine withdrawal

20

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal of clonidine

21

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension

22

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II)

23

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Late Toxicity of Clonidine Withdrawal

24

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Rebound hypertension after sudden discontinuation of methyldopa therapy

25

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine rebound hypertension

26

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Coronary artery syndromes after sudden propranolol withdrawal

27

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

29

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Acute Postoperative Clonidine Withdrawal Syndrome

30

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Letter: Withdrawal of antihypertensive therapy.

31

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal of propranolol and myocardial infarction

32

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal of propranolol and myocardial infarction

33

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Withdrawal of propranolol and myocardial infarction

34

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effects of clonidine withdrawal: possible mechanisms and suggestions for management.

35

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine withdrawal. Mechanism and frequency of rebound hypertension

37

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Failure of labetalol to prevent hypertension due to clonidine withdrawal

38

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Hypertension After Clonidine Withdrawal

39

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Rebound phenomenon during gradual withdrawal of clonidine

40

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine Withdrawal

41

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine-withdrawal syndrome

42

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effect of alpha-methyl DOPA in severe and malignant hypertension

43

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Letter: Rebound hypertension after acute methyldopa withdrawal.

44

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Hyperthyroidism After Propranolol Withdrawal

45

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Abrupt propranolol withdrawal in angina pectoris: Effects on platelet aggregation and exercise tolerance

46

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Editorial: Propranolol withdrawal

47

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Letter: Clonidine withdrawal and blockade

50

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Clonidine and propranolol paradoxical hypertension

53

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Costochondral pain in gastroenterologic practice

54

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Abrupt cessation of clonidine administration: a prospective study

56

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Hypertension in the immediate postoperative period

57

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Combination of clonidine and sotalol in hypertension

62

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Propranolol withdrawal in angina pectoris: A prospective study

63

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Diuretic-induced oedema

66

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Upper limit of autoregulation of cerebral blood flow in the baboon.

67

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects

70

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

72

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Beta-adrenoreceptor blockade in hypertension

73

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients

74

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Beta-blockers and plasma renin activity in hypertension.

75

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

77

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

79

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

80

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Renin and aldosterone suppression in the antihypertensive action of clonidine

81

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Role of renin and aldosterone suppression in the antihypertensive mechanism of clonidine

82

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

The Effect of Clonidine on Plasma Renin Activity in Human Hypertension

84

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Plasma renin and blood pressure during treatment with methyldopa

85

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Plasma Renin Activity and Blood Pressure in Terminal Renal Failure

86

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Effect of Methyldopa on Plasma Renin Activity in Man

87

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Comparison of the Renin Response to Dopamine and Noradrenaline in Normal Subjects and Patients with Autonomic Insufficiency

88

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres)

89

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Myocardial infarction after propranolol withdrawal

91

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Propranolol withdrawal and thyroid hormones in patients with essential hypertension

92

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

The Abrupt Discontinuation of Antihypertensive Treatment

94

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents

95

1 reference

10.1016/0002-8703(81)90317-3

https://api.crossref.org/works/10.1016/0002-8703(81)90317-3

8 August 2023

Identifiers

10.1016/0002-8703(81)90317-3

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40084945&oldid=2104993389"